Antibiotic susceptibility and genotypic characterization of Neisseria gonorrhoeae isolates in the Comunidad Valenciana (Spain): GONOvig project

The increase in sexually transmitted infections (STI) caused by Neisseria gonorrhoeae (NG) worldwide, together with the decrease in antibiotic susceptibility, forced us to understand the epidemiology of gonococcal infection. The GONOvig project analyzed, comparatively following CLSI and EUCAST crite...

Full description

Saved in:
Bibliographic Details
Published inEnfermedades infecciosas y microbiologia clinica (English ed.) Vol. 42; no. 2; pp. 69 - 73
Main Authors Fabregat Bolufer, Aleix Borja, Bueno Ferrando, Felipe, Navarro Ortega, David, Colomina Rodríguez, Javier
Format Journal Article
LanguageEnglish
Published Spain Elsevier España, S.L.U 01.02.2024
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The increase in sexually transmitted infections (STI) caused by Neisseria gonorrhoeae (NG) worldwide, together with the decrease in antibiotic susceptibility, forced us to understand the epidemiology of gonococcal infection. The GONOvig project analyzed, comparatively following CLSI and EUCAST criteria, the antibiotic susceptibility of 227 NG strains collected in thirteen representative hospitals of the Valencia Community (CV) between 2013 and 2018. Additionally, molecular typing of 175 strains using the NG multi-antigen sequence typing technique (NG-MAST) was performed. High rates of resistance to tetracycline (38.2% by CLSI and 50.9% by EUCAST) and ciprofloxacin (49.1% CLSI and 54% EUCAST), and low percentages of resistance to spectinomycin (0%), cefixime (0.5% CLSI but 5.9% EUCAST), and ceftriaxone (1.5% CLSI and 2.4% EUCAST) were detected. Azithromycin resistance was 6% (both CLSI and EUCAST). Molecular analysis revealed the presence of 86 different sequence types (ST), highlighting ST2992 (7.4%), ST3378 (6.9%), ST2400 (4.6%) and ST13288 (6.9%), which was associated with resistance to cefixime (P=.031). The main genogroups (G) were G1407 (13.1%), G2992 (10.3%), G2400 (6.3%) and G387 (3.4%). G1407 and G2400 were associated with resistance to ciprofloxacin (P<.03). Low resistance to ceftriaxone, a worrying resistance to azithromycin and a wide variety of circulating sequence types have been detected, some of which show correlation with certain resistance profiles. El aumento de las infecciones de transmisión sexual producidas por Neisseria gonorrhoeae (NG) a nivel mundial, junto con la disminución de la susceptibilidad antibiótica, obliga a profundizar en la epidemiologia de la infección gonocócica. El proyecto GONOvig analizó, comparativamente siguiendo criterios CLSI y EUCAST, la sensibilidad antibiótica de 227 cepas de NG recogidas en trece hospitales representativos de la Comunidad Valencia (CV) entre los años 2013 y 2018. Adicionalmente, se pudo realizar la tipificación molecular de 175 cepas mediante la técnica NG multi-antigen sequence typing (NG-MAST). Se detectaron elevadas tasas de resistencia a tetraciclina (38,2% por CLSI y 50,9% por EUCAST) y ciprofloxacino (49,1% CLSI y 54% EUCAST), y bajos porcentajes de resistencia a espectinomicina (0%), cefixima (0,5% CLSI pero 5,9% EUCAST) y ceftriaxona (1,5% CLSI y 2,4% EUCAST). La resistencia a azitromicina fue del 6% (tanto CLSI como EUCAST). El análisis molecular reveló la presencia de 86 secuenciotipos (ST) distintos, destacando el ST2992 (7,4%), ST3378 (6,9%), ST2400 (4,6%) y ST13288 (6,9%) el cual presentaba asociación con resistencia a cefixima (P=,031). Los genogrupos (G) mayoritarios fueron el G1407 (13,1%), G2992 (10,3%), G2400 (6,3%) y G387 (3,4%); G1407 y G2400 mostraron asociación con resistencia a ciprofloxacino (P<,03). Se ha detectado una baja resistencia a ceftriaxona, una preocupante resistencia a azitromicina y una gran variedad de secuenciotipos circulantes, algunos de los cuales presentan correlación con determinados perfiles de resistencia.
AbstractList INTRODUCTIONThe increase in sexually transmitted infections (STI) caused by Neisseria gonorrhoeae (NG) worldwide, together with the decrease in antibiotic susceptibility, forced us to understand the epidemiology of gonococcal infection.METHODSThe GONOvig project analyzed, comparatively following CLSI and EUCAST criteria, the antibiotic susceptibility of 227 NG strains collected in thirteen representative hospitals of the Valencia Community (CV) between 2013 and 2018. Additionally, molecular typing of 175 strains using the NG multi-antigen sequence typing technique (NG-MAST) was performed.RESULTSHigh rates of resistance to tetracycline (38.2% by CLSI and 50.9% by EUCAST) and ciprofloxacin (49.1% CLSI and 54% EUCAST), and low percentages of resistance to spectinomycin (0%), cefixime (0.5% CLSI but 5.9% EUCAST), and ceftriaxone (1.5% CLSI and 2.4% EUCAST) were detected. Azithromycin resistance was 6% (both CLSI and EUCAST). Molecular analysis revealed the presence of 86 different sequence types (ST), highlighting ST2992 (7.4%), ST3378 (6.9%), ST2400 (4.6%) and ST13288 (6.9%), which was associated with resistance to cefixime (P=.031). The main genogroups (G) were G1407 (13.1%), G2992 (10.3%), G2400 (6.3%) and G387 (3.4%). G1407 and G2400 were associated with resistance to ciprofloxacin (P<.03).CONCLUSIONLow resistance to ceftriaxone, a worrying resistance to azithromycin and a wide variety of circulating sequence types have been detected, some of which show correlation with certain resistance profiles.
The increase in sexually transmitted infections (STI) caused by Neisseria gonorrhoeae (NG) worldwide, together with the decrease in antibiotic susceptibility, forced us to understand the epidemiology of gonococcal infection. The GONOvig project analyzed, comparatively following CLSI and EUCAST criteria, the antibiotic susceptibility of 227 NG strains collected in thirteen representative hospitals of the Valencia Community (CV) between 2013 and 2018. Additionally, molecular typing of 175 strains using the NG multi-antigen sequence typing technique (NG-MAST) was performed. High rates of resistance to tetracycline (38.2% by CLSI and 50.9% by EUCAST) and ciprofloxacin (49.1% CLSI and 54% EUCAST), and low percentages of resistance to spectinomycin (0%), cefixime (0.5% CLSI but 5.9% EUCAST), and ceftriaxone (1.5% CLSI and 2.4% EUCAST) were detected. Azithromycin resistance was 6% (both CLSI and EUCAST). Molecular analysis revealed the presence of 86 different sequence types (ST), highlighting ST2992 (7.4%), ST3378 (6.9%), ST2400 (4.6%) and ST13288 (6.9%), which was associated with resistance to cefixime (P=.031). The main genogroups (G) were G1407 (13.1%), G2992 (10.3%), G2400 (6.3%) and G387 (3.4%). G1407 and G2400 were associated with resistance to ciprofloxacin (P<.03). Low resistance to ceftriaxone, a worrying resistance to azithromycin and a wide variety of circulating sequence types have been detected, some of which show correlation with certain resistance profiles. El aumento de las infecciones de transmisión sexual producidas por Neisseria gonorrhoeae (NG) a nivel mundial, junto con la disminución de la susceptibilidad antibiótica, obliga a profundizar en la epidemiologia de la infección gonocócica. El proyecto GONOvig analizó, comparativamente siguiendo criterios CLSI y EUCAST, la sensibilidad antibiótica de 227 cepas de NG recogidas en trece hospitales representativos de la Comunidad Valencia (CV) entre los años 2013 y 2018. Adicionalmente, se pudo realizar la tipificación molecular de 175 cepas mediante la técnica NG multi-antigen sequence typing (NG-MAST). Se detectaron elevadas tasas de resistencia a tetraciclina (38,2% por CLSI y 50,9% por EUCAST) y ciprofloxacino (49,1% CLSI y 54% EUCAST), y bajos porcentajes de resistencia a espectinomicina (0%), cefixima (0,5% CLSI pero 5,9% EUCAST) y ceftriaxona (1,5% CLSI y 2,4% EUCAST). La resistencia a azitromicina fue del 6% (tanto CLSI como EUCAST). El análisis molecular reveló la presencia de 86 secuenciotipos (ST) distintos, destacando el ST2992 (7,4%), ST3378 (6,9%), ST2400 (4,6%) y ST13288 (6,9%) el cual presentaba asociación con resistencia a cefixima (P=,031). Los genogrupos (G) mayoritarios fueron el G1407 (13,1%), G2992 (10,3%), G2400 (6,3%) y G387 (3,4%); G1407 y G2400 mostraron asociación con resistencia a ciprofloxacino (P<,03). Se ha detectado una baja resistencia a ceftriaxona, una preocupante resistencia a azitromicina y una gran variedad de secuenciotipos circulantes, algunos de los cuales presentan correlación con determinados perfiles de resistencia.
The increase in sexually transmitted infections (STI) caused by Neisseria gonorrhoeae (NG) worldwide, together with the decrease in antibiotic susceptibility, forced us to understand the epidemiology of gonococcal infection. The GONOvig project analyzed, comparatively following CLSI and EUCAST criteria, the antibiotic susceptibility of 227 NG strains collected in thirteen representative hospitals of the Valencia Community (CV) between 2013 and 2018. Additionally, molecular typing of 175 strains using the NG multi-antigen sequence typing technique (NG-MAST) was performed. High rates of resistance to tetracycline (38.2% by CLSI and 50.9% by EUCAST) and ciprofloxacin (49.1% CLSI and 54% EUCAST), and low percentages of resistance to spectinomycin (0%), cefixime (0.5% CLSI but 5.9% EUCAST), and ceftriaxone (1.5% CLSI and 2.4% EUCAST) were detected. Azithromycin resistance was 6% (both CLSI and EUCAST). Molecular analysis revealed the presence of 86 different sequence types (ST), highlighting ST2992 (7.4%), ST3378 (6.9%), ST2400 (4.6%) and ST13288 (6.9%), which was associated with resistance to cefixime (P=.031). The main genogroups (G) were G1407 (13.1%), G2992 (10.3%), G2400 (6.3%) and G387 (3.4%). G1407 and G2400 were associated with resistance to ciprofloxacin (P<.03). Low resistance to ceftriaxone, a worrying resistance to azithromycin and a wide variety of circulating sequence types have been detected, some of which show correlation with certain resistance profiles.
Author Bueno Ferrando, Felipe
Fabregat Bolufer, Aleix Borja
Colomina Rodríguez, Javier
Navarro Ortega, David
Author_xml – sequence: 1
  givenname: Aleix Borja
  surname: Fabregat Bolufer
  fullname: Fabregat Bolufer, Aleix Borja
  email: aleixborja1987@gmail.com
  organization: Hospital Universitario de Bellvitge, Barcelona, Spain
– sequence: 2
  givenname: Felipe
  surname: Bueno Ferrando
  fullname: Bueno Ferrando, Felipe
  organization: Hospital Clínico Universitario de Valencia, Valencia, Spain
– sequence: 3
  givenname: David
  surname: Navarro Ortega
  fullname: Navarro Ortega, David
  organization: Hospital Clínico Universitario de Valencia, Valencia, Spain
– sequence: 4
  givenname: Javier
  surname: Colomina Rodríguez
  fullname: Colomina Rodríguez, Javier
  organization: Hospital Clínico Universitario de Valencia, Valencia, Spain
BackLink https://www.ncbi.nlm.nih.gov/pubmed/36646588$$D View this record in MEDLINE/PubMed
BookMark eNp9kctqHDEQRUVwiB_xFwSClvZi2mr1U4EszJA4BuNZ5EF2Qi1Vz9TQLXUktWHyE_llazK2ySorSaVbdalzT8mRdRYIeZezLGd5fbXNAEcNGWecZ6zNGBOvyAmvuFgIUfw8-ud-TM5D2DLGuKjzqijfkOOirsu6atsT8ufaRuzQRdQ0zEHDtH8OGHdUWUPXYF3cTelTb5RXOoLH3yqis9T19B4whFRRdO2s837jQAHF4AYVIVC0NG6ALt04WzTK0B9qAKtRWUUvvk4K7eUHerO6Xz3gmk7ebUHHt-R1r4YA50_nGfn--dO35ZfF3ermdnl9t9B5VbYL0TFmWtaLqtOdKBrVADR5V3Z1KYC3RqVyqXhfGkjStmKNNr2oK9BcNJyx4oxcHOYm318zhChHTNsPg7Lg5iB5kxAViVmRpMVBqr0LwUMvJ4-j8juZM7kPQ27l3zDkPgzJWpnCSF3vnwzmbgTz0vOMPgk-HgSQ1nxA8DJoTHjAoE8gpHH4X4NHhs2gyQ
Cites_doi 10.1086/383047
10.1016/j.eimc.2013.03.010
10.1371/journal.pmed.1002366
10.2807/1560-7917.ES.2019.24.8.1900118
10.15585/mmwr.mm6950a6
10.1128/AAC.05760-11
10.2807/ese.18.03.20358-en
10.1016/j.eimc.2015.01.017
10.2471/BLT.18.228486
10.1016/j.eimc.2019.12.002
10.1093/jac/dks162
10.2807/ese.16.14.19833-en
10.1093/jac/dkw279
10.1128/JCM.01453-07
10.1136/sti.2008.029694
10.1128/JCM.01236-09
10.1177/0956462419886775
ContentType Journal Article
Copyright 2022 Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica
Copyright © 2022 Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica. Published by Elsevier España, S.L.U. All rights reserved.
Copyright_xml – notice: 2022 Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica
– notice: Copyright © 2022 Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica. Published by Elsevier España, S.L.U. All rights reserved.
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
DOI 10.1016/j.eimce.2022.08.009
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic

MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
DocumentTitleAlternate Susceptibilidad antibiótica y caracterización genotípica de aislados de Neisseria gonorrhoeae circulantes en la Comunidad Valenciana (España): proyecto GONOvig
EISSN 2529-993X
EndPage 73
ExternalDocumentID 10_1016_j_eimce_2022_08_009
36646588
S2529993X23000011
Genre Journal Article
GeographicLocations Spain
GeographicLocations_xml – name: Spain
GroupedDBID --M
0R~
AACTN
AAEDT
AAEDW
AAIAV
AAKOC
AALRI
AAOAW
AAQFI
AAXUO
ABMAC
ACDAQ
ACGFS
ACRLP
ADBBV
AEBSH
AFTJW
AFXIZ
AGUBO
AIEXJ
AIKHN
AITUG
AKRWK
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
AXJTR
BNPGV
CJTIS
EBS
EFJIC
EFLBG
EJD
FDB
FIRID
KOM
M41
O9-
ROL
SPCBC
SSH
SSI
SSZ
T5K
~G-
AFJKZ
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
ID FETCH-LOGICAL-c1548-9b00d80f95bcb937a7ee71b4b649e28dabcb4a2f4de9b08507cdf965ec2972003
IEDL.DBID AIKHN
ISSN 2529-993X
IngestDate Fri Aug 16 01:55:15 EDT 2024
Thu Sep 26 15:54:07 EDT 2024
Sat Sep 28 08:14:05 EDT 2024
Sat Mar 16 16:13:15 EDT 2024
IsPeerReviewed true
IsScholarly true
Issue 2
Keywords Bacterial
Molecular typing
Neisseria gonorrhoeae
Bacteriano
Drug resistance
Resistencia antibiótica
Caracterización molecular
Language English
License Copyright © 2022 Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica. Published by Elsevier España, S.L.U. All rights reserved.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c1548-9b00d80f95bcb937a7ee71b4b649e28dabcb4a2f4de9b08507cdf965ec2972003
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMID 36646588
PQID 2766430023
PQPubID 23479
PageCount 5
ParticipantIDs proquest_miscellaneous_2766430023
crossref_primary_10_1016_j_eimce_2022_08_009
pubmed_primary_36646588
elsevier_sciencedirect_doi_10_1016_j_eimce_2022_08_009
PublicationCentury 2000
PublicationDate 2024-Feb
PublicationDateYYYYMMDD 2024-02-01
PublicationDate_xml – month: 02
  year: 2024
  text: 2024-Feb
PublicationDecade 2020
PublicationPlace Spain
PublicationPlace_xml – name: Spain
PublicationTitle Enfermedades infecciosas y microbiologia clinica (English ed.)
PublicationTitleAlternate Enferm Infecc Microbiol Clin (Engl Ed)
PublicationYear 2024
Publisher Elsevier España, S.L.U
Publisher_xml – name: Elsevier España, S.L.U
References European Centre for Disease Prevention and Control. Gonorrhoea: Annual Epidemiological Report for 2018 [accessed 4 Jul 2022]. Available from
Cámara, Serra, Ayats, Bastida, Carnicer-Pont, Andreu (bib0140) 2012; 67
Rowley, Vander Hoorn, Korenromp, Low, Unemo, Abu-Raddad (bib0005) 2019; 97
World Health Organization (WHO). 2019 Antibacterial agents in clinical development: an analysis of the antibacterial clinical development pipeline [accessed 14 Jul 2022]. Available from
Martin, Ison, Aanensen, Fenton, Spratt (bib0065) 2004; 189
European Centre for Disease Prevention and Control. Gonococcal antimicrobial susceptibility surveillance in Europe – Results summary 2017 [accessed 6 Jul 2022]. Available from
The European Committee on Antimicrobial Susceptibility Testing. Breakpoint tables for interpretation of MICs and zone diameters. Version 10.0 [accessed 6 Jul 2022]. Available from
Cobo, Cabezas-Fernández, Cabeza-Barrera (bib0105) 2016; 34
Castaño Aroca, Acosta Boga, Lozano Rodríguez, Chouman Arcas (bib0115) 2020; 38
European Centre for Disease Prevention and Control. Gonococcal antimicrobial susceptibility surveillance in Europe – Results summary 2018. 2020 [accessed 7 Jul 2022]. Available from
Palmer, Young, Graham, Dave (bib0035) 2008; 84
Fifer, Saunders, Soni, Sadiq, FitzGerald (bib0025) 2020; 31
Chisholm, Unemo, Quaye, Johansson, Cole, Ison (bib0070) 2013; 18
World Health Organization. 2018 Report on global sexually transmitted infection surveillance [accessed 6 Jul 2022]. Available from
2019.
Alirol, Wi, Bala, Bazzo, Chen, Deal (bib0150) 2017; 14
Bilek, Martin, Bell, Kinghorn, Ison, Spratt (bib0030) 2007; 45
2020.
Unemo, Ross, Serwin, Gomberg, Cusini, Jensen (bib0020) 2020; 32
Ison, Hussey, Sankar, Evans, Alexander (bib0145) 2011; 16
Cobo, Cabezas-Fernández, Avivar (bib0110) 2019; 32
European Centre for Disease Prevention and Control. Molecular typing of Neisseria gonorrhoeae – a study of 2013 isolates. 2018 [accessed 7 Jul 2022]. Available from
.
Serra Pladevall J. Neisseria gonorrhoeae: monitorització de la sensibilitat antimicrobiana, estudi de la dinàmica poblacional i caracterització molecular de les resistències. 2016 [accessed 6 Jul 2022]. Available from
Carannante, Vacca, Lo Presti, Stefanelli (bib0130) 2019; 32
St Cyr, Barbee, Workowski, Bachmann, Pham, Schlanger (bib0015) 2020; 69
Jennison, Whiley, Lahra, Graham, Cole, Hughes (bib0085) 2019; 24
Guo, Ye, Zhao, Ma, Yang, Luo (bib0050) 2014; 6
Clinical and Laboratory Standards Institute (CLSI). Performance Standards for Antimicrobial Susceptibility Testing. 30th ed. CLSI supplement M100. (ISBN 978-1-68440-066-9 [Print]; ISBN 978-1-68440-067-6 [Electronic]).
Unemo, Golparian, Nicholas, Ohnishi, Gallay, Sednaoui (bib0135) 2012; 56
Jacobsson, Golparian, Cole, Spiteri, Martin, Bergheim (bib0075) 2016; 71
Serra-Pladevall, Barberá-Gracia, Roig-Carbajosa, Juvé-Saumell, Gonzalez-Lopez, Bartolomé-Comas (bib0095) 2013; 31
2018.
Monfort, Caro, Devaux, Delannoy, Brisse, Sednaoui (bib0040) 2009; 47
10.1016/j.eimce.2022.08.009_bib0060
Guo (10.1016/j.eimce.2022.08.009_bib0050) 2014; 6
10.1016/j.eimce.2022.08.009_bib0080
10.1016/j.eimce.2022.08.009_bib0120
Cobo (10.1016/j.eimce.2022.08.009_bib0110) 2019; 32
Castaño Aroca (10.1016/j.eimce.2022.08.009_bib0115) 2020; 38
St Cyr (10.1016/j.eimce.2022.08.009_bib0015) 2020; 69
10.1016/j.eimce.2022.08.009_bib0045
10.1016/j.eimce.2022.08.009_bib0100
Rowley (10.1016/j.eimce.2022.08.009_bib0005) 2019; 97
Monfort (10.1016/j.eimce.2022.08.009_bib0040) 2009; 47
Chisholm (10.1016/j.eimce.2022.08.009_bib0070) 2013; 18
Jacobsson (10.1016/j.eimce.2022.08.009_bib0075) 2016; 71
Unemo (10.1016/j.eimce.2022.08.009_bib0020) 2020; 32
Jennison (10.1016/j.eimce.2022.08.009_bib0085) 2019; 24
Martin (10.1016/j.eimce.2022.08.009_bib0065) 2004; 189
Carannante (10.1016/j.eimce.2022.08.009_bib0130) 2019; 32
10.1016/j.eimce.2022.08.009_bib0090
Ison (10.1016/j.eimce.2022.08.009_bib0145) 2011; 16
Serra-Pladevall (10.1016/j.eimce.2022.08.009_bib0095) 2013; 31
10.1016/j.eimce.2022.08.009_bib0010
Fifer (10.1016/j.eimce.2022.08.009_bib0025) 2020; 31
Alirol (10.1016/j.eimce.2022.08.009_bib0150) 2017; 14
10.1016/j.eimce.2022.08.009_bib0055
Bilek (10.1016/j.eimce.2022.08.009_bib0030) 2007; 45
Palmer (10.1016/j.eimce.2022.08.009_bib0035) 2008; 84
Cobo (10.1016/j.eimce.2022.08.009_bib0105) 2016; 34
10.1016/j.eimce.2022.08.009_bib0125
Cámara (10.1016/j.eimce.2022.08.009_bib0140) 2012; 67
Unemo (10.1016/j.eimce.2022.08.009_bib0135) 2012; 56
References_xml – volume: 6
  start-page: 534
  year: 2014
  end-page: 538
  ident: bib0050
  article-title: Comparative study of MALDI-TOF MS and VITEK 2 in bacteria identification
  publication-title: J Thorac Dis.
  contributor:
    fullname: Luo
– volume: 16
  year: 2011
  ident: bib0145
  article-title: Gonorrhoea treatment failures to cefixime and azithromycin in England, 2010
  publication-title: Eurosurveillance.
  contributor:
    fullname: Alexander
– volume: 38
  start-page: 348
  year: 2020
  end-page: 349
  ident: bib0115
  article-title: Antimicrobial susceptibility study of Neisseria gonorrhoeae in the health area of the University and Polytechnic La Fe Hospital of Valencia
  publication-title: Enferm Infecc Microbiol Clin.
  contributor:
    fullname: Chouman Arcas
– volume: 71
  start-page: 3109
  year: 2016
  end-page: 3116
  ident: bib0075
  article-title: WGS analysis and molecular resistance mechanisms of azithromycin-resistant (MIC &2 mg/L) Neisseria gonorrhoeae isolates in Europe from 2009 to 2014
  publication-title: J Antimicrob Chemother.
  contributor:
    fullname: Bergheim
– volume: 84
  start-page: 280
  year: 2008
  end-page: 284
  ident: bib0035
  article-title: Prediction of antibiotic resistance using Neisseria gonorrhoeae multi-antigen sequence typing
  publication-title: Sex Transm Infect.
  contributor:
    fullname: Dave
– volume: 69
  start-page: 1911
  year: 2020
  end-page: 1916
  ident: bib0015
  article-title: Update to CDC’s Treatment Guidelines for Gonococcal Infection, 2020
  publication-title: MMWR Morb Mortal Wkly Rep.
  contributor:
    fullname: Schlanger
– volume: 34
  start-page: 3
  year: 2016
  end-page: 7
  ident: bib0105
  article-title: Antimicrobial susceptibility and typing of Neisseria gonorrhoeae strains from Southern Spain, 2012-2014
  publication-title: Enferm Infecc Microbiol Clin.
  contributor:
    fullname: Cabeza-Barrera
– volume: 97
  start-page: 548
  year: 2019
  end-page: 562
  ident: bib0005
  article-title: Chlamydia, gonorrhoea, trichomoniasis and syphilis: global prevalence and incidence estimates, 2016
  publication-title: Bull World Health Organ.
  contributor:
    fullname: Abu-Raddad
– volume: 24
  start-page: 1
  year: 2019
  end-page: 4
  ident: bib0085
  article-title: Genetic relatedness of ceftriaxone-resistant and high-level azithromycin resistant Neisseria gonorrhoeae cases, United Kingdom and Australia, February to April 2018
  publication-title: Eurosurveillance.
  contributor:
    fullname: Hughes
– volume: 32
  start-page: 8
  year: 2019
  end-page: 15
  ident: bib0130
  article-title: Sorveglianza di laboratorio del l’antibiotico-resistenza in Neisseria gonorrhoeae: risultati del biennio 2016-2017
  publication-title: Not Ist Super Sanità.
  contributor:
    fullname: Stefanelli
– volume: 56
  start-page: 1273
  year: 2012
  end-page: 1280
  ident: bib0135
  article-title: High-level cefixime and ceftriaxone-resistant Neisseria gonorrhoeae in France: novel penA mosaic allele in a successful international clone causes treatment failure
  publication-title: Antimicrob Agents Chemother.
  contributor:
    fullname: Sednaoui
– volume: 32
  start-page: 1018
  year: 2020
  end-page: 1026
  ident: bib0020
  article-title: 2020 European guideline for the diagnosis and treatment of gonorrhoea in adults
  publication-title: Int J STD AIDS.
  contributor:
    fullname: Jensen
– volume: 67
  start-page: 1858
  year: 2012
  end-page: 1860
  ident: bib0140
  article-title: Molecular characterization of two high-level ceftriaxone-resistant Neisseria gonorrhoeae isolates detected in Catalonia, Spain
  publication-title: J Antimicrob Chemother.
  contributor:
    fullname: Andreu
– volume: 45
  start-page: 3564
  year: 2007
  end-page: 3567
  ident: bib0030
  article-title: Concordance between Neisseria gonorrhoeae genotypes recovered from known sexual contacts
  publication-title: J Clin Microbiol.
  contributor:
    fullname: Spratt
– volume: 47
  start-page: 3540
  year: 2009
  end-page: 3545
  ident: bib0040
  article-title: First Neisseria gonorrhoeae genotyping analysis in France: identification of a strain cluster with reduced susceptibility to ceftriaxone
  publication-title: J Clin Microbiol.
  contributor:
    fullname: Sednaoui
– volume: 31
  start-page: 579
  year: 2013
  end-page: 583
  ident: bib0095
  article-title: Neisseria gonorrhoeae: antimicrobial resistance and study of population dynamics. Situation in Barcelona in 2011
  publication-title: Enferm Infecc Microbiol Clin.
  contributor:
    fullname: Bartolomé-Comas
– volume: 31
  start-page: 4
  year: 2020
  end-page: 15
  ident: bib0025
  article-title: 2018 UK national guideline for the management of infection with Neisseria gonorrhoeae
  publication-title: Int J STD AIDS.
  contributor:
    fullname: FitzGerald
– volume: 18
  start-page: 20358
  year: 2013
  ident: bib0070
  article-title: Molecular epidemiological typing within the European Gonococcal Antimicrobial Resistance Surveillance Programme reveals predominance of a multidrug-resistant clone
  publication-title: Eurosurveillance.
  contributor:
    fullname: Ison
– volume: 32
  start-page: 114
  year: 2019
  end-page: 120
  ident: bib0110
  article-title: Typing and antimicrobial susceptibility of 134 Neisseria gonorrhoeae strains from Southern Spain
  publication-title: Rev Esp Quimioter.
  contributor:
    fullname: Avivar
– volume: 14
  year: 2017
  ident: bib0150
  article-title: Multidrug-resistant gonorrhea: a research and development roadmap to discover new medicines
  publication-title: PLoS Med.
  contributor:
    fullname: Deal
– volume: 189
  start-page: 1497
  year: 2004
  end-page: 1505
  ident: bib0065
  article-title: Rapid sequence‐based identification of gonococcal transmission clusters in a large metropolitan area
  publication-title: J Infect Dis.
  contributor:
    fullname: Spratt
– volume: 189
  start-page: 1497
  year: 2004
  ident: 10.1016/j.eimce.2022.08.009_bib0065
  article-title: Rapid sequence‐based identification of gonococcal transmission clusters in a large metropolitan area
  publication-title: J Infect Dis.
  doi: 10.1086/383047
  contributor:
    fullname: Martin
– volume: 31
  start-page: 579
  year: 2013
  ident: 10.1016/j.eimce.2022.08.009_bib0095
  article-title: Neisseria gonorrhoeae: antimicrobial resistance and study of population dynamics. Situation in Barcelona in 2011
  publication-title: Enferm Infecc Microbiol Clin.
  doi: 10.1016/j.eimc.2013.03.010
  contributor:
    fullname: Serra-Pladevall
– volume: 14
  year: 2017
  ident: 10.1016/j.eimce.2022.08.009_bib0150
  article-title: Multidrug-resistant gonorrhea: a research and development roadmap to discover new medicines
  publication-title: PLoS Med.
  doi: 10.1371/journal.pmed.1002366
  contributor:
    fullname: Alirol
– volume: 6
  start-page: 534
  year: 2014
  ident: 10.1016/j.eimce.2022.08.009_bib0050
  article-title: Comparative study of MALDI-TOF MS and VITEK 2 in bacteria identification
  publication-title: J Thorac Dis.
  contributor:
    fullname: Guo
– volume: 24
  start-page: 1
  year: 2019
  ident: 10.1016/j.eimce.2022.08.009_bib0085
  article-title: Genetic relatedness of ceftriaxone-resistant and high-level azithromycin resistant Neisseria gonorrhoeae cases, United Kingdom and Australia, February to April 2018
  publication-title: Eurosurveillance.
  doi: 10.2807/1560-7917.ES.2019.24.8.1900118
  contributor:
    fullname: Jennison
– volume: 32
  start-page: 1018
  year: 2020
  ident: 10.1016/j.eimce.2022.08.009_bib0020
  article-title: 2020 European guideline for the diagnosis and treatment of gonorrhoea in adults
  publication-title: Int J STD AIDS.
  contributor:
    fullname: Unemo
– ident: 10.1016/j.eimce.2022.08.009_bib0120
– volume: 69
  start-page: 1911
  year: 2020
  ident: 10.1016/j.eimce.2022.08.009_bib0015
  article-title: Update to CDC’s Treatment Guidelines for Gonococcal Infection, 2020
  publication-title: MMWR Morb Mortal Wkly Rep.
  doi: 10.15585/mmwr.mm6950a6
  contributor:
    fullname: St Cyr
– volume: 56
  start-page: 1273
  year: 2012
  ident: 10.1016/j.eimce.2022.08.009_bib0135
  article-title: High-level cefixime and ceftriaxone-resistant Neisseria gonorrhoeae in France: novel penA mosaic allele in a successful international clone causes treatment failure
  publication-title: Antimicrob Agents Chemother.
  doi: 10.1128/AAC.05760-11
  contributor:
    fullname: Unemo
– volume: 18
  start-page: 20358
  year: 2013
  ident: 10.1016/j.eimce.2022.08.009_bib0070
  article-title: Molecular epidemiological typing within the European Gonococcal Antimicrobial Resistance Surveillance Programme reveals predominance of a multidrug-resistant clone
  publication-title: Eurosurveillance.
  doi: 10.2807/ese.18.03.20358-en
  contributor:
    fullname: Chisholm
– volume: 34
  start-page: 3
  year: 2016
  ident: 10.1016/j.eimce.2022.08.009_bib0105
  article-title: Antimicrobial susceptibility and typing of Neisseria gonorrhoeae strains from Southern Spain, 2012-2014
  publication-title: Enferm Infecc Microbiol Clin.
  doi: 10.1016/j.eimc.2015.01.017
  contributor:
    fullname: Cobo
– ident: 10.1016/j.eimce.2022.08.009_bib0055
– volume: 97
  start-page: 548
  year: 2019
  ident: 10.1016/j.eimce.2022.08.009_bib0005
  article-title: Chlamydia, gonorrhoea, trichomoniasis and syphilis: global prevalence and incidence estimates, 2016
  publication-title: Bull World Health Organ.
  doi: 10.2471/BLT.18.228486
  contributor:
    fullname: Rowley
– volume: 38
  start-page: 348
  year: 2020
  ident: 10.1016/j.eimce.2022.08.009_bib0115
  article-title: Antimicrobial susceptibility study of Neisseria gonorrhoeae in the health area of the University and Polytechnic La Fe Hospital of Valencia
  publication-title: Enferm Infecc Microbiol Clin.
  doi: 10.1016/j.eimc.2019.12.002
  contributor:
    fullname: Castaño Aroca
– volume: 67
  start-page: 1858
  year: 2012
  ident: 10.1016/j.eimce.2022.08.009_bib0140
  article-title: Molecular characterization of two high-level ceftriaxone-resistant Neisseria gonorrhoeae isolates detected in Catalonia, Spain
  publication-title: J Antimicrob Chemother.
  doi: 10.1093/jac/dks162
  contributor:
    fullname: Cámara
– ident: 10.1016/j.eimce.2022.08.009_bib0080
– ident: 10.1016/j.eimce.2022.08.009_bib0045
– volume: 16
  year: 2011
  ident: 10.1016/j.eimce.2022.08.009_bib0145
  article-title: Gonorrhoea treatment failures to cefixime and azithromycin in England, 2010
  publication-title: Eurosurveillance.
  doi: 10.2807/ese.16.14.19833-en
  contributor:
    fullname: Ison
– ident: 10.1016/j.eimce.2022.08.009_bib0060
– ident: 10.1016/j.eimce.2022.08.009_bib0010
– volume: 71
  start-page: 3109
  year: 2016
  ident: 10.1016/j.eimce.2022.08.009_bib0075
  article-title: WGS analysis and molecular resistance mechanisms of azithromycin-resistant (MIC &2 mg/L) Neisseria gonorrhoeae isolates in Europe from 2009 to 2014
  publication-title: J Antimicrob Chemother.
  doi: 10.1093/jac/dkw279
  contributor:
    fullname: Jacobsson
– volume: 32
  start-page: 8
  year: 2019
  ident: 10.1016/j.eimce.2022.08.009_bib0130
  article-title: Sorveglianza di laboratorio del l’antibiotico-resistenza in Neisseria gonorrhoeae: risultati del biennio 2016-2017
  publication-title: Not Ist Super Sanità.
  contributor:
    fullname: Carannante
– volume: 45
  start-page: 3564
  year: 2007
  ident: 10.1016/j.eimce.2022.08.009_bib0030
  article-title: Concordance between Neisseria gonorrhoeae genotypes recovered from known sexual contacts
  publication-title: J Clin Microbiol.
  doi: 10.1128/JCM.01453-07
  contributor:
    fullname: Bilek
– volume: 32
  start-page: 114
  year: 2019
  ident: 10.1016/j.eimce.2022.08.009_bib0110
  article-title: Typing and antimicrobial susceptibility of 134 Neisseria gonorrhoeae strains from Southern Spain
  publication-title: Rev Esp Quimioter.
  contributor:
    fullname: Cobo
– ident: 10.1016/j.eimce.2022.08.009_bib0100
– volume: 84
  start-page: 280
  year: 2008
  ident: 10.1016/j.eimce.2022.08.009_bib0035
  article-title: Prediction of antibiotic resistance using Neisseria gonorrhoeae multi-antigen sequence typing
  publication-title: Sex Transm Infect.
  doi: 10.1136/sti.2008.029694
  contributor:
    fullname: Palmer
– volume: 47
  start-page: 3540
  year: 2009
  ident: 10.1016/j.eimce.2022.08.009_bib0040
  article-title: First Neisseria gonorrhoeae genotyping analysis in France: identification of a strain cluster with reduced susceptibility to ceftriaxone
  publication-title: J Clin Microbiol.
  doi: 10.1128/JCM.01236-09
  contributor:
    fullname: Monfort
– ident: 10.1016/j.eimce.2022.08.009_bib0090
– ident: 10.1016/j.eimce.2022.08.009_bib0125
– volume: 31
  start-page: 4
  year: 2020
  ident: 10.1016/j.eimce.2022.08.009_bib0025
  article-title: 2018 UK national guideline for the management of infection with Neisseria gonorrhoeae
  publication-title: Int J STD AIDS.
  doi: 10.1177/0956462419886775
  contributor:
    fullname: Fifer
SSID ssj0002961534
Score 2.2880208
Snippet The increase in sexually transmitted infections (STI) caused by Neisseria gonorrhoeae (NG) worldwide, together with the decrease in antibiotic susceptibility,...
INTRODUCTIONThe increase in sexually transmitted infections (STI) caused by Neisseria gonorrhoeae (NG) worldwide, together with the decrease in antibiotic...
SourceID proquest
crossref
pubmed
elsevier
SourceType Aggregation Database
Index Database
Publisher
StartPage 69
SubjectTerms Anti-Bacterial Agents - pharmacology
Azithromycin
Bacterial
Bacteriano
Caracterización molecular
Cefixime - pharmacology
Ceftriaxone - pharmacology
Ciprofloxacin - pharmacology
Drug resistance
Genotype
Gonorrhea - epidemiology
Humans
Microbial Sensitivity Tests
Molecular typing
Neisseria gonorrhoeae
Neisseria gonorrhoeae - genetics
Resistencia antibiótica
Spain - epidemiology
Title Antibiotic susceptibility and genotypic characterization of Neisseria gonorrhoeae isolates in the Comunidad Valenciana (Spain): GONOvig project
URI https://dx.doi.org/10.1016/j.eimce.2022.08.009
https://www.ncbi.nlm.nih.gov/pubmed/36646588
https://search.proquest.com/docview/2766430023
Volume 42
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Na9wwEBXp5tJLSUk_Nk2DAjm0ELMbWZat3paQZJulG2iSdm9CkuVEgcrLfhTyK_qXOyPbC4Wmh56MJQsLjTR6kt48EXLERGY5IO-ksEbCAgWGoqyGZVJVIjOAgIWJCnxfpmJ8yy9n2WyLnHaxMEirbH1_49Ojt25TBm1rDubeD65ZBq5UpjMA0RHZPCPbMB1x3iPbo8-T8XSz1cIkoho8X8YiCZbp9Ici08v5HxYVMxmLap7ITfz7HPUUBo1z0fkOedGCSDpq6vmSbLmwS36NAsZ_1JBGl-tlpKtE5usj1aGkKMa6epxDpt1oNDchmLSu6NTFc3mv6V0d6sXivnbaUQ8dE7Eo9YECUKTgPNbBl7qk3zQGK0HX0vTD9Vz78PETvbiaXv30d7Td3HlFbs_Pbk7HSXvdQmJx3ZKgOmJZDCuZGbBbmuvcufzEcCO4dKwoNSRzzSpeOvi0ACBpy0qKzFkmc-S4vSa9UAf3ltCikil4Bg3LI8YF44VNnQZ3Yo0RTJ_kfXLcNbCaN6oaqqObPahoD4X2UHhF5lD2ieiMoP7oHAr8_r8LHnYmUzBs8CxEB1evl4rlArAYIpY-edPYclOTFLIAmBV7__vbd-Q5vPGG3L1PeqvF2r0H7LIyB23fxOfk6_fJb_C0760
link.rule.ids 315,786,790,24144,27957,27958,45714
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Nb9QwELXK9gAXVMTXQgEjcQCJaHcdx4l7W1WULW3TQ1u0N8t2nGIknNV-VOqv6F_ujJOshAQcuNqxYnnGz8_2zDMhH5jILAfmnRTWSNigwFSU9bhK6lpkBhiwMFGB76wUsyv-bZ7Nd8hhnwuDYZUd9reYHtG6Kxl1ozlaeD-6YBlAqUznQKIjs3lAdnmWT_iA7E6PT2bl9qiFSWQ1eL-MTRJs0-sPxUgv539ZVMxkLKp5Ymzin9eov3HQuBYd7ZHHHYmk07afT8iOC0_J3TRg_kcDZXS1WcVwlRj5ekt1qCiKsa5vF1BptxrNbQombWpaungv7zW9bkKzXP5onHbUg2MiF6U-UCCKFMBjE3ylK_pdY7ISuJamHy8W2odPB_TreXl-469pd7jzjFwdfbk8nCXdcwuJxX1LguqIVTGuZWbAbmmuc-fyieFGcOlYUWko5prVvHLwaQFE0la1FJmzTOYY4_acDEIT3EtCi1qmgAwatkeMC8YLmzoNcGKNEUxP8iH53A-wWrSqGqoPN_upoj0U2kPhE5ljOSSiN4L6zTkU4P6_G77vTaZg2uBdiA6u2awUywVwMWQsQ_KiteW2JylUATErXv3vb9-Rh7PLs1N1elyevCaPoIa3gd77ZLBebtwb4DFr87bz03vT-vD6
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Antibiotic+susceptibility+and+genotypic+characterization+of+Neisseria+gonorrhoeae+isolates+in+the+Comunidad+Valenciana+%28Spain%29%3A+GONOvig+project&rft.jtitle=Enfermedades+infecciosas+y+microbiologia+clinica+%28English+ed.%29&rft.au=Fabregat+Bolufer%2C+Aleix+Borja&rft.au=Bueno+Ferrando%2C+Felipe&rft.au=Navarro+Ortega%2C+David&rft.au=Colomina+Rodr%C3%ADguez%2C+Javier&rft.date=2024-02-01&rft.eissn=2529-993X&rft.volume=42&rft.issue=2&rft.spage=69&rft.epage=73&rft_id=info:doi/10.1016%2Fj.eimce.2022.08.009&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2529-993X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2529-993X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2529-993X&client=summon